Córdova Eliane Silva Machado, Santos Lidiane Rodrigues Dos, Toebe Daiane, Moraes Maria Antonieta Pereira de, Souza Emiliane Nogueira de
Fundação Universitária de Cardiologia do Rio Grande de Sul, Instituto de Cardiologia, Porto Alegre, RS, Brazil.
Fundação Universitária de Cardiologia do Rio Grande de Sul, Instituto de Cardiologia, Programa de Residência Multiprofissional em Saúde, Porto Alegre, RS, Brazil.
Rev Esc Enferm USP. 2018 Dec 10;52:e03410. doi: 10.1590/S1980-220X2017041003410.
To examine the incidence of hemorrhagic complications in patients undergoing radial cardiac catheterization and using a hemostatic device for arterial compression.
A prospective cohort study conducted with patients undergoing elective cardiac catheterization in two hemodynamic laboratories in southern Brazil. The TR Band® radial compression device was used during 4 hours for hemostasis of the arterial puncture site. Hematomas and minor bleeding were the outcomes evaluated.
A total of 244 patients were evaluated. The mean age was 63.5±10.9 years, 61.9% were male, 73.8% had systemic arterial hypertension (SAH) and 42.8% were dyslipidemic. Type I hematoma occurred in 1.2% of patients and minor bleeding in 9% after removal of the device. There was no significant association between hematomas and bleeding, and patients who used oral anticoagulants (p=0.604) and prior use of antiplatelets (p=0.958).
The use of the hemostatic device for radial artery compression was safe in clinical practice and there was a low incidence of hematomas and minor bleeding after radial coronary angiography.
研究接受桡动脉心脏导管插入术并使用止血装置进行动脉压迫的患者出血并发症的发生率。
在巴西南部的两个血流动力学实验室对接受择期心脏导管插入术的患者进行前瞻性队列研究。使用TR Band®桡动脉压迫装置对动脉穿刺部位进行4小时止血。评估血肿和轻微出血情况。
共评估了244例患者。平均年龄为63.5±10.9岁，61.9%为男性，73.8%患有系统性动脉高血压（SAH），42.8%患有血脂异常。I型血肿发生在1.2%的患者中，装置移除后9%的患者出现轻微出血。血肿与出血之间无显著关联，使用口服抗凝剂的患者（p=0.604）和先前使用抗血小板药物的患者（p=0.958）也无显著关联。
在临床实践中，使用止血装置压迫桡动脉是安全的，桡动脉冠状动脉造影术后血肿和轻微出血的发生率较低。
